Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A
C.M. Gleeson
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorN. Morar
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorI. Staveley
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorC.B. Bunker
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorC.M. Gleeson
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorN. Morar
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorI. Staveley
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorC.B. Bunker
Department of Dermatology, Chelsea and Westminster NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, U.K. E-mail: [email protected]
Search for more papers by this authorFunding sources: none.
Conflicts of interest: none declared.
References
- 1 Mosam A, Morar N. Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach. J Dermatolog Treat 2004; 15: 353–9.
- 2 Mana J, Marcoval J, Graells J et al. Cutaneous involvement in sarcoidosis: relationship to systemic disease. Arch Dermatol 1997; 133: 882–7.
- 3 Graefe T, Konrad H, Barta U et al. Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 2001; 145: 354–5.
- 4 Courtois JM, Husson C, Dalac M et al. Cutaneous and articular sarcoidosis. Improvement by PUVA therapy. Presse Med 1987; 16: 1334–5.
- 5 Patterson JW, Fitzwater JE. Treatment of hypopigmented sarcoidosis with 8-methoxypsoralen and long wave ultraviolet light. Int J Dermatol 1982; 21: 476–80.
- 6 Wilsmann-Theis D, Bieber T, Novak N. Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis. Dermatology 2008; 217: 343–6.
- 7 Prasse A, Georges CG, Biller H et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000; 122: 241–8.
- 8 Dumay O, Karam A, Vian L et al. Ultraviolet A1 exposure of human skin results in Langerhans cell depletion and reduction of epidermal antigen-presenting cell function: partial protection by a broad-spectrum sunscreen. Br J Dermatol 2001; 144: 1161–8.
- 9 Morita A, Werfel T, Stege H et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of UVA radiation phototherapy. J Exp Med 1997; 186: 1763–8.
- 10 Halliday GM, Bestak R, Yuen KS et al. UVA-induced immunosuppression. Mutat Res 1998; 422: 139–45.
